• Policy
• Handok paces its efforts to reimburse Pivlaz in KOR
• by Lee, Tak-Sun Jun 11, 2024 05:47am

• Company
• 'Novel drugs·CDMO competitiveness↑'
• by Son, Hyung-Min Jun 10, 2024 05:41am

• Product
• Will Osimertinib emerge as the standard of care
• by Park, sang-jun Jun 10, 2024 05:41am

• Company
• Chronic kidney disease drug ‘Kerendia’ can be prescribed
• by Eo, Yun-Ho Jun 10, 2024 05:41am

• Company
• Pharma company MRs illegally work for CSOs on the sideline
• by Lee, Seok-Jun Jun 10, 2024 05:41am

• Policy
• Roche applies for Ocrevus' reimbursement in KOR
• by Lee, Tak-Sun Jun 10, 2024 05:41am

• Opinion
• [Reporter’s View] Finances limit reimbursement of drugs
• by Eo, Yun-Ho Jun 7, 2024 05:51am

• Company
• Immuno-oncology drugs demonstrate additional benefit at ASCO
• by Son, Hyung-Min Jun 7, 2024 05:50am

• Company
• "Breast cancer treatments received positive reviews"
• by Son, Hyung-Min Jun 7, 2024 05:50am

• Company
• ‘Fully utilize the various IBD treatment options available'
• by Eo, Yun-Ho Jun 7, 2024 05:50am